![Peter Radovich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Radovich
President på
MIRUM PHARMACEUTICALS, INC.
Förmögenhet: 6 M $ per 2026-05-31
Profil
Peter Radovich is President & Chief Operating Officer at Mirum Pharmaceuticals, Inc. since 2024, with employment at the firm starting in 2020.
Former roles include Independent Director at Rain Oncology, Inc. from 2018 to 2024; Senior Vice President-Operations at Global Blood Therapeutics, Inc. from 2016 to 2020; Vice President-Global Product Kyprolis at Onyx Pharmaceuticals, Inc. from 2013 to 2014; Senior Director & VP-Program Leadership at Onyx Pharmaceuticals, Inc. from 2004 to 2006; and Principal at Chiron Corp.
from 2004 to 2006.
Education includes an MBA from the University of Washington and undergraduate studies at Texas Christian University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-05 | 57 260 ( 0,09 % ) | 6 M $ | 2026-05-31 |
Aktiva positioner av Peter Radovich
| Företag | Position | Start |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | President | 2024-01-16 |
Tidigare kända positioner av Peter Radovich
| Företag | Position | Slut |
|---|---|---|
| RAIN ONCOLOGY INC. | Direktör/Styrelseledamot | 2024-01-25 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Verksamhetschef | 2020-04-01 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Företagsledare/Principal | 2014-01-01 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Direktör/Styrelseledamot | 2006-09-01 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Företagsledare/Principal | 2006-01-01 |
Peter Radovichs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
67
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas Christian University
 Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage precision oncology company that develops therapeutics for cancer patients | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
